Procurement of human derived monoclonal antibodies and recombinant antigens
Ended Awarded Last action
- Contract number
- HT942626FE075
- Awardee
-
Mapp Biopharmaceutical, Inc. UEI M9V9QTHR1H28
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $10,250
Award facts
- Contract value 100% obligated
- $10,250.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92121, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency issued a delivery order to Mapp Biopharmaceutical, Inc., on July 2, 2026, with a ceiling value of $10,250 for procurement of human-derived monoclonal antibodies and recombinant antigens. Performance will be completed by October 1, 2026.
Place of performance is San Diego, CA 92121. This delivery order is issued under firm fixed price terms.
Quick answers
Who was awarded contract HT942626FE075?
HT942626FE075 was awarded to Mapp Biopharmaceutical, Inc. by Defense Health Agency (Department of Defense) on July 2, 2026.
How much is contract HT942626FE075 worth?
The government has obligated $10,250 on HT942626FE075.
Is contract HT942626FE075 an order under another contract?
Yes. HT942626FE075 is a delivery order under HT942525D0009, an indefinite delivery contract.
Was contract HT942626FE075 competed?
The extent of competition for HT942626FE075 was not competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award